A detailed history of Propel Bio Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Propel Bio Management, LLC holds 6,567,858 shares of APLT stock, worth $60.5 Million. This represents 32.38% of its overall portfolio holdings.

Number of Shares
6,567,858
Previous 6,567,858 -0.0%
Holding current value
$60.5 Million
Previous $30.7 Billion 82.01%
% of portfolio
32.38%
Previous 19.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.04 - $6.37 $1.84 Million - $2.9 Million
455,952 Added 7.46%
6,567,858 $30.7 Billion
Q1 2024

May 13, 2024

BUY
$2.25 - $7.4 $1.66 Million - $5.45 Million
736,924 Added 13.71%
6,111,906 $41.6 Billion
Q4 2023

Feb 14, 2024

BUY
$1.84 - $3.35 $9.89 Million - $18 Million
5,374,982 New
5,374,982 $18 Billion

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $442M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Propel Bio Management, LLC Portfolio

Follow Propel Bio Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Propel Bio Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Propel Bio Management, LLC with notifications on news.